• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型快速粪便钙卫蛋白检测系统在小儿炎症性肠病患者中的应用价值

Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases.

作者信息

Inoue Keisuke, Aomatsu Tomoki, Yoden Atsushi, Okuhira Takeru, Kaji Emiri, Tamai Hiroshi

机构信息

Department of Pediatrics, Osaka Medical College, Takatsuki, Osaka, Japan.

出版信息

J Gastroenterol Hepatol. 2014;29(7):1406-12. doi: 10.1111/jgh.12578.

DOI:10.1111/jgh.12578
PMID:24635100
Abstract

BACKGROUND AND AIM

Fecal calprotectin (FC) has become a reliable biomarker for intestinal inflammation in inflammatory bowel diseases (IBDs). However, a simple and rapid assay to replace conventional ELISA is necessary for wider use in clinical practice. In this study, we investigated the usefulness of a novel method for measuring FC using a colloidal gold aggregation (CGA) assay for assessing mucosal inflammation in pediatric IBDs.

METHODS

FC levels were determined by ELISA and CGA assay in 309 fecal samples (ulcerative colitis [UC]: 131; Crohn's disease [CD]: 121; healthy controls: 57). For endoscopic evaluation, the modified Matts' grading system for UC and the simple endoscopic score for CD were used.

RESULTS

A strong correlation was found between the FC values determined by the two methods (r = 0.98, P < 0.01). FC levels, determined by CGA assay, strongly correlated with the endoscopic score for UC (r = 0.70, P < 0.01) and CD (r = 0.58, P < 0.01). In the UC patients with endoscopic remission, the FC levels determined by CGA assay (median: 31.5 μg/g, n = 14) were as low as in healthy controls. For patients in clinical remission but showing an active status endoscopically, FC was more likely to be abnormal than commonly used laboratory markers.

CONCLUSIONS

Our simple and rapid assay system has excellent performance for assessing mucosal inflammation of IBDs and can be replaced for ELISA. Practical application of this assay system enables us to use FC measurement more widely in clinical practice.

摘要

背景与目的

粪便钙卫蛋白(FC)已成为炎症性肠病(IBD)肠道炎症的可靠生物标志物。然而,需要一种简单快速的检测方法来替代传统酶联免疫吸附测定(ELISA),以便在临床实践中更广泛地应用。在本研究中,我们调查了一种使用胶体金聚集(CGA)测定法测量FC以评估儿童IBD黏膜炎症的新方法的实用性。

方法

采用ELISA和CGA测定法测定309份粪便样本中的FC水平(溃疡性结肠炎[UC]:131例;克罗恩病[CD]:121例;健康对照:57例)。内镜评估采用UC改良的马茨分级系统和CD简单内镜评分。

结果

两种方法测定的FC值之间存在强相关性(r = 0.98,P < 0.01)。通过CGA测定法测定的FC水平与UC(r = 0.70,P < 0.01)和CD(r = 0.58,P < 0.01)的内镜评分密切相关。在内镜缓解的UC患者中,通过CGA测定法测定的FC水平(中位数:31.5μg/g,n = 14)与健康对照一样低。对于临床缓解但内镜显示活跃状态的患者,FC比常用实验室指标更可能异常。

结论

我们简单快速的检测系统在评估IBD黏膜炎症方面具有优异性能,可替代ELISA。该检测系统的实际应用使我们能够在临床实践中更广泛地使用FC测量。

相似文献

1
Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases.一种新型快速粪便钙卫蛋白检测系统在小儿炎症性肠病患者中的应用价值
J Gastroenterol Hepatol. 2014;29(7):1406-12. doi: 10.1111/jgh.12578.
2
Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease.粪便钙卫蛋白是儿童炎症性肠病患者疾病活动的有用标志物。
Dig Dis Sci. 2011 Aug;56(8):2372-7. doi: 10.1007/s10620-011-1633-y. Epub 2011 Mar 11.
3
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.粪便钙卫蛋白是炎症性肠病内镜下病变的替代标志物。
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.
4
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.粪便钙卫蛋白作为评估炎症性肠病患儿黏膜炎症严重程度的可靠非侵入性标志物。
Dig Liver Dis. 2008 Jul;40(7):547-53. doi: 10.1016/j.dld.2008.01.017. Epub 2008 Mar 20.
5
The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.粪便钙卫蛋白在评估炎症性肠病活动中的作用。
Korean J Intern Med. 2019 Jan;34(1):72-80. doi: 10.3904/kjim.2016.324. Epub 2018 Jan 20.
6
Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.粪便几丁质酶 3 样蛋白 1:儿科炎症性肠病疾病活动的新型生物标志物。
Aliment Pharmacol Ther. 2011 Oct;34(8):941-8. doi: 10.1111/j.1365-2036.2011.04805.x. Epub 2011 Aug 16.
7
[Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].[粪便钙卫蛋白:一种用于炎症性肠病的诊断工具]
Rev Med Suisse. 2012 Sep 5;8(352):1669-70, 1672-3.
8
FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.粪便钙卫蛋白:巴西胃肠道症状患者病因诊断的水平
Arq Gastroenterol. 2015 Jan-Mar;52(1):50-4. doi: 10.1590/S0004-28032015000100011.
9
Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.粪便钙卫蛋白作为炎症性肠病患儿黏膜炎症严重程度的标志物。
Wien Klin Wochenschr. 2016 Apr;128(7-8):253-9. doi: 10.1007/s00508-015-0915-3. Epub 2015 Dec 10.
10
Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.快速粪便钙卫蛋白水平评估和炎症性肠病问卷(SIBDQ)评分可准确检测临床缓解期炎症性肠病(IBD)患者的活动性黏膜炎症:一项前瞻性研究。
J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.

引用本文的文献

1
Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease.基于胶乳增强免疫比浊法的快速粪便钙卫蛋白检测在炎症性肠病中的验证。
Sci Rep. 2024 Jan 18;14(1):1653. doi: 10.1038/s41598-024-51580-z.
2
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer.C反应蛋白在预测癌症患者免疫介导性腹泻和结肠炎的严重程度及反应中的作用
J Cancer. 2023 Jun 26;14(10):1913-1919. doi: 10.7150/jca.84261. eCollection 2023.
3
Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.
儿科克罗恩病的临床活动与内镜严重程度之间的一致性较差:诱导治疗前后。
Dig Dis Sci. 2022 Mar;67(3):997-1006. doi: 10.1007/s10620-021-06917-3. Epub 2021 Apr 5.
4
Correlation of the endoscopic findings for small and large bowels in pediatric patients with established Crohn's disease.确诊克罗恩病的儿科患者小肠和大肠内镜检查结果的相关性
J Clin Biochem Nutr. 2019 May;64(3):257-264. doi: 10.3164/jcbn.18-83. Epub 2018 Nov 28.
5
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn's disease?: a systematic review.粪便钙卫蛋白能否同等准确地测量小肠和大肠克罗恩病的疾病活动度?一项系统评价
Intest Res. 2019 Apr;17(2):160-170. doi: 10.5217/ir.2018.00114. Epub 2019 Feb 7.
6
The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.用于同时测量粪便中钙卫蛋白和血红蛋白的新型乳胶凝集比浊免疫分析系统。
Intest Res. 2019 Apr;17(2):202-209. doi: 10.5217/ir.2018.00086. Epub 2018 Dec 14.
7
Correlation of rapid point-of-care send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease.儿科炎症性肠病中即时快速送检粪便钙卫蛋白监测的相关性
World J Gastrointest Pharmacol Ther. 2017 May 6;8(2):127-130. doi: 10.4292/wjgpt.v8.i2.127.
8
Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective study.粪便钙卫蛋白连续监测用于评估克罗恩病回结肠切除术后无症状患者的内镜复发情况:一项长期前瞻性研究
Therap Adv Gastroenterol. 2016 Sep;9(5):664-70. doi: 10.1177/1756283X16646562. Epub 2016 May 1.
9
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.粪便钙卫蛋白:其在炎症性肠病管理中的范围及应用
J Gastroenterol. 2016 May;51(5):434-46. doi: 10.1007/s00535-016-1182-4. Epub 2016 Feb 20.
10
Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?粪便免疫化学检测作为炎症性肠病的生物标志物:它能与粪便钙卫蛋白相媲美吗?
Intest Res. 2016 Jan;14(1):5-14. doi: 10.5217/ir.2016.14.1.5. Epub 2016 Jan 25.